Miss Bo Goovaerts
University of Antwerp, Antwerp (Belgium)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
A newly developed small-molecule ErbB4 agonist reduces reactive cardiac fibrosis and adverse ventricular remodelling after myocardial infarction in a sex-specific manner.
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Heart failure: bench to bedside
A novel ERBB4 agonist attenuates cardiac remodelling after myocardial infarction in a sex-specific manner
Event: Heart Failure 2024
Topic: Pharmacotherapy
Session: Tailoring heart failure therapies on patient profiles
